355 related articles for article (PubMed ID: 37568717)
1. Clinical Applications of Immunotherapy for Recurrent Glioblastoma in Adults.
Olivet MM; Brown MC; Reitman ZJ; Ashley DM; Grant GA; Yang Y; Markert JM
Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568717
[TBL] [Abstract][Full Text] [Related]
2. Emerging therapies for glioblastoma: current state and future directions.
Rong L; Li N; Zhang Z
J Exp Clin Cancer Res; 2022 Apr; 41(1):142. PubMed ID: 35428347
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
Medikonda R; Pant A; Lim M
Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
[TBL] [Abstract][Full Text] [Related]
4. The Development of Immunotherapy for the Treatment of Recurrent Glioblastoma.
Liu X; Zhao Z; Dai W; Liao K; Sun Q; Chen D; Pan X; Feng L; Ding Y; Wei S
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686584
[TBL] [Abstract][Full Text] [Related]
5. How We Treat Recurrent Glioblastoma Today and Current Evidence.
Chaul-Barbosa C; Marques DF
Curr Oncol Rep; 2019 Oct; 21(10):94. PubMed ID: 31606796
[TBL] [Abstract][Full Text] [Related]
6. Emerging immunotherapies for glioblastoma.
Desai R; Suryadevara CM; Batich KA; Farber SH; Sanchez-Perez L; Sampson JH
Expert Opin Emerg Drugs; 2016 Jun; 21(2):133-45. PubMed ID: 27223671
[TBL] [Abstract][Full Text] [Related]
7. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R
Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of glioblastoma: Recent advances and future prospects.
Yuan B; Wang G; Tang X; Tong A; Zhou L
Hum Vaccin Immunother; 2022 Nov; 18(5):2055417. PubMed ID: 35344682
[TBL] [Abstract][Full Text] [Related]
9. Recent advances and future challenges of tumor vaccination therapy for recurrent glioblastoma.
Zhao B; Wu J; Li H; Wang Y; Wang Y; Xing H; Wang Y; Ma W
Cell Commun Signal; 2023 Apr; 21(1):74. PubMed ID: 37046332
[TBL] [Abstract][Full Text] [Related]
10. The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma.
Zhang L; Jiang Y; Zhang G; Wei S
Front Immunol; 2023; 14():1238233. PubMed ID: 37731483
[TBL] [Abstract][Full Text] [Related]
11. Combination immunotherapy strategies for glioblastoma.
Chan HY; Choi J; Jackson C; Lim M
J Neurooncol; 2021 Feb; 151(3):375-391. PubMed ID: 33611705
[TBL] [Abstract][Full Text] [Related]
12. Advances in Glioblastoma Therapy: An Update on Current Approaches.
Angom RS; Nakka NMR; Bhattacharya S
Brain Sci; 2023 Oct; 13(11):. PubMed ID: 38002496
[TBL] [Abstract][Full Text] [Related]
13. Current Advances in Immunotherapy for Glioblastoma Multiforme and Future Prospects.
Chowdhury S; Bappy MH; Clocchiatti-Tuozzo S; Cheeti S; Chowdhury S; Patel V
Cureus; 2021 Dec; 13(12):e20604. PubMed ID: 35103180
[TBL] [Abstract][Full Text] [Related]
14. Advances in immunotherapy for glioblastoma multiforme.
Mahmoud AB; Ajina R; Aref S; Darwish M; Alsayb M; Taher M; AlSharif SA; Hashem AM; Alkayyal AA
Front Immunol; 2022; 13():944452. PubMed ID: 36311781
[TBL] [Abstract][Full Text] [Related]
15. The Safety of available immunotherapy for the treatment of glioblastoma.
Farber SH; Elsamadicy AA; Atik AF; Suryadevara CM; Chongsathidkiet P; Fecci PE; Sampson JH
Expert Opin Drug Saf; 2017 Mar; 16(3):277-287. PubMed ID: 27989218
[TBL] [Abstract][Full Text] [Related]
16. Current Immunotherapies for Glioblastoma Multiforme.
Huang B; Li X; Li Y; Zhang J; Zong Z; Zhang H
Front Immunol; 2020; 11():603911. PubMed ID: 33767690
[TBL] [Abstract][Full Text] [Related]
17. Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook.
Gedeon PC; Champion CD; Rhodin KE; Woroniecka K; Kemeny HR; Bramall AN; Bernstock JD; Choi BD; Sampson JH
Expert Rev Clin Pharmacol; 2020 Oct; 13(10):1147-1158. PubMed ID: 32862726
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy Resistance in Glioblastoma.
Wang EJ; Chen JS; Jain S; Morshed RA; Haddad AF; Gill S; Beniwal AS; Aghi MK
Front Genet; 2021; 12():750675. PubMed ID: 34976006
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in Glioblastoma: A Clinical Perspective.
Desbaillets N; Hottinger AF
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359621
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives.
Sener U; Ruff MW; Campian JL
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
